Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SAA2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | SPIB | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | CCM2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | RSL24D1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | IL18 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | KBTBD7 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | RFXANK | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | GPX8 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | CBARP | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | PPFIA4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |